A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/70 (2006.01)
Patent
CA 2718943
Described herein are compositions comprising opioids, opioid antagonists and prodrugs of the same, formulations comprising opioids, opioid antagonists and prodrugs of the same, and methods of using opioids, opioid antagonists and prodrugs of the same. One embodiment described herein relates to the transdermal administration of a buprenorphine and encapsulated nal-trexone in an abuse-resistant formulation for treating and preventing diseases and/or disorders.
La présente invention concerne des compositions comprenant des opioïdes, des antagonistes dopioïdes et des promédicaments de ceux-ci, des formulations comprenant des opioïdes, des antagonistes dopioïdes et des promédicaments de ceux-ci, et des procédés dutilisation dopioïdes, des antagonistes dopioïdes et des promédicaments de ceux-ci. Un mode de réalisation présentement décrit concerne ladministration transdermique de buprénorphine et de naltrexone encapsulées dans une formulation inviolable pour traiter et prévenir des maladies et/ou des troubles.
Banks Stan Lee
Stinchcomb Audra Lynn
Alltranz Inc.
Mccarthy Tetrault Llp
LandOfFree
Abuse deterrent transdermal formulations of opiate agonists... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Abuse deterrent transdermal formulations of opiate agonists..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Abuse deterrent transdermal formulations of opiate agonists... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1497249